Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - Esperion Therapeutics, Inc. | a2223469zex-31_1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Esperion Therapeutics, Inc. | Financial_Report.xls |
| XML - IDEA: XBRL DOCUMENT - Esperion Therapeutics, Inc. | R9999.htm |
| 10-K - 10-K - Esperion Therapeutics, Inc. | a2223469z10-k.htm |
| EX-32.1 - EX-32.1 - Esperion Therapeutics, Inc. | a2223469zex-32_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
- •
- Registration Statement (Form S-3 No. 333-201198) of Esperion Therapeutics, Inc.
- •
- Registration Statement (Form S-8 No. 333-201378) pertaining to the 2013 Stock Option and Incentive Plan of Esperion
Therapeutics, Inc.
- •
- Registration Statement (Form S-8 No. 333-194536) pertaining to the 2013 Stock Option and Incentive Plan of Esperion
Therapeutics, Inc.
- •
- Registration Statement (Form S-8 No. 333-189738) pertaining to the 2008 Incentive Stock Option and Restricted Stock Plan and the 2013 Stock Option and Incentive Plan of Esperion Therapeutics, Inc.
of our report dated March 10, 2015 with respect to the financial statements of Esperion Therapeutics, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2014.
/s/ Ernst & Young LLP
Detroit,
Michigan
March 10, 2015
Consent of Independent Registered Public Accounting Firm